Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL17433546 | 0.64 | S1PR1 (0.31) | — | |
| Phosphoric Acid SCHEMBL27482642 | 0.64 | CYP1A2 (0.43) | FDPSMMP1MMP2MMP3HTR1A | |
| Phosphoric Acid SCHEMBL11271597 | 0.62 | S1PR1 (0.43) | — | |
| Phosphoric Acid SCHEMBL28801115 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| Phosphoric Acid SCHEMBL9359318 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| Phosphoric Acid SCHEMBL192007 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| N,N-Dimethylethanaminium SCHEMBL9049895 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| N,N-Dimethylethanaminium SCHEMBL9049890 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| Phosphoric Acid SCHEMBL192006 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 | |
| Phosphoric Acid SCHEMBL21359160 | 0.61 | FDPS (0.46) | FDPSMMP1MMP2MMP3MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20070135645-A1 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135645-A1 | Process for the preparation of guanidinium salts | GMPS, AGPS, PFAS | FDPS 84/4885MMP1 4667/4885MMP2 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.